• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不愿培训,不愿开方:全科医生开具阿片类药物替代疗法的障碍

Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy.

作者信息

Longman Christine, Temple-Smith Meredith, Gilchrist Gail, Lintzeris Nicholas

机构信息

Department of General Practice and Primary Health Care Academic Centre, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, 200 Berkeley Street, Carlton, Vic. 3053, Australia.

出版信息

Aust J Prim Health. 2012;18(4):346-51. doi: 10.1071/PY11100.

DOI:10.1071/PY11100
PMID:22950844
Abstract

Opioid substitution therapy (OST) is a well-recognised, evidence-based treatment for opioid dependence. Since the early 1990s, Australia has used a community-based general practitioner (GP) model ofprescribing, particularly within the state of Victoria, where over 85% of OST prescribing is undertaken by GPs in community settings. Yet the majority of GPs invited to complete the required OST training decline the offer, while of those who complete training, the majority prescribe to few or no patients. This study aimed to determine the reasons for this. Twenty-two in-depth interviews were conducted with Victorian GPs exploring the reasons why the majority declined training, and for trained GPs, why they prescribed to few or no patients in the first 12 months after training. General practitioners who declined to train were predominantly influenced by negative experiences with drug-seeking patients, although other secondary reasons also affected their decision. Some GPs who completed the training were prevented from prescribing by several structural and operational barriers, many of which could be addressed. Fear of deskilling with time became a further impediment. General practitioners who became regular prescribers were highly committed with lengthy general practice experience. Concerns exist about the recruitment process for OST prescriber training, where nearly all GPs decline the offer of training, and the barriers that prevent GPs prescribing after training. Action is needed to address barriers to GP OST training and prescribing, and further research is necessary to ascertain measures required to facilitate long-term prescribing.

摘要

阿片类药物替代疗法(OST)是一种公认的、基于证据的阿片类药物依赖治疗方法。自20世纪90年代初以来,澳大利亚采用了一种以社区为基础的全科医生(GP)处方模式,特别是在维多利亚州,该州超过85%的OST处方由社区环境中的全科医生开具。然而,大多数被邀请完成所需OST培训的全科医生拒绝了这一提议,而在完成培训的医生中,大多数人很少或根本没有给患者开处方。本研究旨在确定其原因。对维多利亚州的全科医生进行了22次深入访谈,探讨大多数人拒绝培训的原因,以及对于接受培训的全科医生,他们在培训后的前12个月里很少或根本没有给患者开处方的原因。拒绝培训的全科医生主要受到与寻求药物患者的负面经历的影响,尽管其他次要原因也影响了他们的决定。一些完成培训的全科医生由于一些结构和操作障碍而无法开处方,其中许多障碍是可以解决的。对随着时间推移技能退化的恐惧成为了进一步的障碍。成为常规处方医生的全科医生有着长期的全科医疗经验且高度投入。人们对OST处方医生培训的招募过程存在担忧,几乎所有全科医生都拒绝培训提议,以及培训后阻止全科医生开处方的障碍。需要采取行动解决全科医生OST培训和开处方的障碍,并且有必要进行进一步研究以确定促进长期开处方所需的措施。

相似文献

1
Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy.不愿培训,不愿开方:全科医生开具阿片类药物替代疗法的障碍
Aust J Prim Health. 2012;18(4):346-51. doi: 10.1071/PY11100.
2
Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.维多利亚州全科医生开具美沙酮和丁丙诺啡的处方模式:授权后的头 5 年。
Drug Alcohol Rev. 2011 Jul;30(4):355-9. doi: 10.1111/j.1465-3362.2010.00212.x. Epub 2010 Jun 22.
3
Opioid substitution therapy--a study of GP participation in prescribing.阿片类药物替代疗法——全科医生参与处方开具情况的一项研究。
Aust Fam Physician. 2011 Apr;40(4):241-5.
4
Paediatric homoeopathy in general practice: where, when and why?全科医疗中的儿科顺势疗法:地点、时间与原因?
Br J Clin Pharmacol. 2005 Jun;59(6):743-9. doi: 10.1111/j.1365-2125.2004.02213.x.
5
Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.在初级医疗保健中,为何符合条件的患者未被开具阿司匹林处方?一项定性研究指出改进措施。
BMC Fam Pract. 2003 Jul 18;4:9. doi: 10.1186/1471-2296-4-9.
6
How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium.如何克服阿片类药物替代治疗中的障碍?对比利时全科医生的一项定性研究。
Eur J Gen Pract. 2016 Jun;22(2):134-40. doi: 10.3109/13814788.2015.1120286. Epub 2016 Jan 22.
7
Proton pump inhibitors: perspectives of patients and their GPs.质子泵抑制剂:患者及其全科医生的观点。
Br J Gen Pract. 2001 Sep;51(470):703-11.
8
Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.影响基于实践的教育干预以支持循证处方的可行性和可接受性的因素:一项定性研究
Fam Pract. 2004 Dec;21(6):661-9. doi: 10.1093/fampra/cmh614. Epub 2004 Nov 4.
9
An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy.对新南威尔士州全科医生提供阿片类药物替代疗法的影响因素进行考察。
Drug Alcohol Rev. 2013 Sep;32(5):495-503. doi: 10.1111/dar.12046. Epub 2013 Apr 28.
10
Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?全科医疗中慢性心力衰竭治疗的感知障碍;它们会影响治疗效果吗?
BMC Fam Pract. 2005 May 3;6(1):19. doi: 10.1186/1471-2296-6-19.

引用本文的文献

1
Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study.不列颠哥伦比亚省与成为阿片类激动剂治疗处方医生相关的基层医疗医生特征:一项回顾性病例对照研究。
Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5.
2
Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study.美沙酮或丁丙诺啡治疗的患者的自我污名化和感知污名化是否仍然是阿片类激动剂治疗上市 50 年后的一个问题?观察性 STIGMA 研究。
Addict Sci Clin Pract. 2024 Oct 16;19(1):74. doi: 10.1186/s13722-024-00506-1.
3
Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour.
在澳大利亚全科医疗环境中,针对开具阿片类药物治疗慢性疼痛的患者,使用计划行为理论对处方阿片类药物使用障碍进行诊断和管理:一项定性研究。
BMC Prim Care. 2024 Jul 3;25(1):236. doi: 10.1186/s12875-024-02474-6.
4
Challenges of methadone maintenance treatment decentralisation from Vietnamese primary care providers' perspectives.从越南基层医疗服务提供者的视角看美沙酮维持治疗去中心化面临的挑战。
Drug Alcohol Rev. 2023 May;42(4):803-814. doi: 10.1111/dar.13613. Epub 2023 Feb 27.
5
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes.澳大利亚新南威尔士州 2001-2018 年阿片类激动剂治疗处方医生保留情况:对治疗系统的影响及对患者结局的潜在影响。
Drug Alcohol Depend. 2021 Feb 1;219:108464. doi: 10.1016/j.drugalcdep.2020.108464. Epub 2020 Dec 19.
6
Real-time prescription monitoring: helping people at risk of harm.实时处方监测:帮助处于伤害风险中的人们。
Aust Prescr. 2020 Oct;43(5):164-167. doi: 10.18773/austprescr.2020.050. Epub 2020 Oct 1.
7
The management of opiate use disorders in France: results of an observational survey of general practitioners.法国阿片类药物使用障碍的管理:全科医生观察性调查结果
Addict Sci Clin Pract. 2015 Jun 28;10:16. doi: 10.1186/s13722-015-0037-2.
8
Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.德国阿片类物质替代治疗中的结构性障碍 - 初级保健医生调查。
Subst Abuse Treat Prev Policy. 2013 Jul 22;8:26. doi: 10.1186/1747-597X-8-26.